Status:
UNKNOWN
Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M
Lead Sponsor:
Neurological Associates of West Los Angeles
Conditions:
Complex Regional Pain Syndromes
Neuralgia
Eligibility:
All Genders
23-77 years
Brief Summary
Alpha 2 macroglobulin (A2M) is a plasma protein that acts as a molecular trap for inflammatory factors such as tumor necrosis factor (TNF). After plasma is enriched for A2M, it may be injected for tre...
Detailed Description
Regional pain in the neck, shoulder and arm is a common problem when there is exposure to repetitive work with a prevalence of about fifty percent. In the absence of a widespread pain conditions, and ...
Eligibility Criteria
Inclusion
- Inclusionary Criteria:
- All patients had daily disabling cervical brachial pain that was continuously present for at least six months.
- After examination by one or both of the authors, patients who were diagnosed as having a condition related to musculotendinous pain (MTPS), neuropathic Thoracic Outlet Syndrome (NTOS), or Complex Regional Pain Syndrome (CRPS) qualified for treatment and inclusion in the chart review.
- Exclusionary Criteria:
- N/A
- (retrospective analysis of clinical treatment)
Exclusion
Key Trial Info
Start Date :
September 24 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04066933
Start Date
September 24 2018
End Date
December 1 2023
Last Update
September 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurological Associates of West Los Angeles
Santa Monica, California, United States, 90403